本庶
佑
born
january
27
1942
japanese
physician
scientist
immunologist
2018
nobel
prize
physiology
medicine
best
known
identification
programmed
cell
death
protein
1
pd
1
also
known
molecular
identification
cytokine
il
4
il
5
well
discovery
activation
induced
cytidine
deaminase
aid
essential
class
switch
recombination
somatic
hypermutation
elected
foreign
associate
academy
science
state
2001
member
german
academy
natural
scientist
leopoldina
2003
also
member
japan
academy
2005
2018
awarded
nobel
prize
physiology
medicine
along
p
together
2014
tang
prize
biopharmaceutical
achievement
born
kyoto
1942
completed
degree
1966
faculty
medicine
kyoto
university
1975
received
ph
degree
medical
chemistry
supervision
yasutomi
nishizuka
hayaishi
visiting
fellow
department
embryology
carnegie
institution
washington
1971
1973
moved
u
institute
health
nih
bethesda
maryland
studied
genetic
basis
immune
response
institute
child
health
human
development
fellow
1973
1977
followed
many
year
nih
fogarty
scholar
residence
starting
1992
part
time
also
assistant
professor
faculty
medicine
university
tokyo
1974
1979
professor
department
genetics
osaka
university
school
medicine
1979
1984
professor
department
medical
chemistry
kyoto
university
faculty
medicine
1984
2005
since
2005
professor
department
immunology
genomic
medicine
kyoto
university
faculty
medicine
president
shizuoka
prefecture
public
university
corporation
2012
2017
member
japanese
society
immunology
served
president
1999
2000
also
honorary
member
association
immunologist
2017
became
deputy
director
general
distinguished
professor
kyoto
university
institute
advanced
study
kuias
covid
19
pandemic
false
claim
believed
novel
coronavirus
manufactured
laboratory
chinese
city
wuhan
widely
disseminated
internet
many
language
bbc
reality
check
team
reported
statement
published
website
kyoto
university
said
greatly
saddened
name
used
spread
false
accusation
misinformation
established
basic
conceptual
framework
class
switch
recombination
presented
model
explaining
antibody
gene
rearrangement
class
switch
1980
1982
verified
validity
elucidating
dna
structure
succeeded
cdna
cloning
il
4
il
5
cytokine
involved
class
switching
il
2
receptor
alpha
chain
1986
went
discover
aid
2000
demonstrating
importance
class
switch
recombination
somatic
hypermutation
1992
first
identified
pd
1
inducible
gene
activated
lymphocyte
discovery
significantly
contributed
establishment
cancer
immunotherapy
principle
pd
1
blockade
received
several
award
honor
life
2016
kyoto
prize
basic
science
discovery
mechanism
responsible
functional
diversification
antibody
immunoregulatory
molecule
clinical
application
pd
1
2018
shared
nobel
prize
physiology
medicine
immunologist
p
previously
also
shared
tang
prize
biopharmaceutical
2014
major
award
honor
received
1981
noguchi
hideyo
memorial
award
medicine
1981
asahi
prize
1984
kihara
prize
genetics
society
japan
1984
osaka
prize
1985
baelz
prize
1988
takeda
medical
prize
1992
kitasato
award
1993
uehara
prize
1996
imperial
prize
japan
academy
2000
person
cultural
merit
2001
foreign
associate
u
academy
science
2012
prize
2013
order
culture
2014
b
coley
award
2015
v
md
memorial
award
2016
kyoto
prize
2016
keio
medical
prize
2016
fudan
zhongzhi
award
2016
reuters
citation
laureate
2017
alpert
foundation
prize
2018
nobel
prize
physiology
medicine
